본문 바로가기
KERD
논문KCI 등재

Extended-spectrum β-lactamase 생성균주에 의한 지역사회 획득 소아 요로 감염의 위험 인자

Risk Factors for Community-onset Urinary Tract Infections due to Extended-spectrum β-lactamase Producing Bacteria in Children

김지희|이택진|김남효
대한감염학회 (The Korean Society Of Infectious Diseases)|2009.12|Infection and Chemotherapy|제41권 제6호|pp. 333-341

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

ChildrenUrinary tract infectionExtended-spectrum β-lactamase
주제분류내과학

초록

Background:Extended-spectrum β-lactamase (ESBL) producing bacteria have been increasingly recognized in the community. The aim of this study was to identify risk factors for community-onset urinary tract infections (UTIs) by ESBL producers in children. Materials and Methods:We analyzed 854 episodes of community-onset UTIs in children diagnosed at CHA Bundang Medical Center from January, 2004 to April, 2009. The presence of ESBL in Escherichia coli and Klebsiella spp. was screened and confirmed by VITEK®-2 ESBL test. Controls were matched in a 2:1 ratio to case patients by age and sex. The clinical characteristics, risk factors, antimicrobial resistance, and treatment efficacy were compared with controls. Results:The most common pathogen was Escherichia coli (681 isolates), followed by Klebsiella pneumoniae (60 isolates), Enterococcus faecalis (23 isolates), etc. The number of isolated ESBL producers among the pathogens E. coli and K. pneumoniae was 25 (3.7%) and 7 isolates (11.7%), respectively. No significant differences were noted as to the UTI history prior to the present treatment, underlying urogenital anomaly, and clinical characteristics. Use of any antibiotics within a month (P=0.012, Odds ratio, 6.341, 95% confidence interval, 1.492 to 26.955) was related to the increased risk of community-onset UTI by ESBL producers. Conclusions:ESBL-producing bacteria has been identified in pediatric community-onset UTI, and the use of any antibiotics within the previous month was related to the increased risk of UTI by ESBL producers. Therefore, careful selection and use of antibiotics should be recommended for community-onset UTI in children.

Abstract

Background:Extended-spectrum β-lactamase (ESBL) producing bacteria have been increasingly recognized in the community. The aim of this study was to identify risk factors for community-onset urinary tract infections (UTIs) by ESBL producers in children. Materials and Methods:We analyzed 854 episodes of community-onset UTIs in children diagnosed at CHA Bundang Medical Center from January, 2004 to April, 2009. The presence of ESBL in Escherichia coli and Klebsiella spp. was screened and confirmed by VITEK®-2 ESBL test. Controls were matched in a 2:1 ratio to case patients by age and sex. The clinical characteristics, risk factors, antimicrobial resistance, and treatment efficacy were compared with controls. Results:The most common pathogen was Escherichia coli (681 isolates), followed by Klebsiella pneumoniae (60 isolates), Enterococcus faecalis (23 isolates), etc. The number of isolated ESBL producers among the pathogens E. coli and K. pneumoniae was 25 (3.7%) and 7 isolates (11.7%), respectively. No significant differences were noted as to the UTI history prior to the present treatment, underlying urogenital anomaly, and clinical characteristics. Use of any antibiotics within a month (P=0.012, Odds ratio, 6.341, 95% confidence interval, 1.492 to 26.955) was related to the increased risk of community-onset UTI by ESBL producers. Conclusions:ESBL-producing bacteria has been identified in pediatric community-onset UTI, and the use of any antibiotics within the previous month was related to the increased risk of UTI by ESBL producers. Therefore, careful selection and use of antibiotics should be recommended for community-onset UTI in children.

참고문헌 (40)

  1. Elder JS, "Urinary tract infections in Nelson textbook of Pediatrics" (2007), W.B. Saunders Co.
  2. Prajapati BS, "Advances in management of urinary tract infections", Indian J Pediatr, 75, pp.809~814 (2008)
  3. 이수영, "소아 원외 요로감염 환아에서 분리된 E. coli에 대한cefixime을 포함한 경구 항생제의 감수성 연구", Korean Journal of Pediatrics, 49(7), pp.777~783 (2006), 대한소아과학회
  4. Pitout JD, "Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community", J Antimicrob Chemother, 56, pp.52~59 (2005)
  5. 이정원, "지역사회 획득 소아 요로검염에서 Extended-Spectrum b-Lactamase 생성 Escherichia coli의 발생과 위험인자", 대한소아신장학회지, 8(2), pp.214~222 (2004), 대한소아신장학회
  6. Pea C, "Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit", J Hosp Infect, 35, pp.9~16 (1997)
  7. Rice LB, "Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antiobiotics", Pharmacotherapy, 19, pp.120S~128S (1999)
  8. Demir S, "Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study", J Paediatr Child Health, 44, pp.548~553 (2008)
  9. Hwang MH, "Clinical and molecular-biologic study of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit", J Korean Soc Neonatol, 8, pp.25~32 (2001)
  10. 전누리, "단일병원 신생아 중환자실에서 Extend Spectrum β - Lactamase 생성 균주 출현의 역학 및 임상적 특징", Korean Journal of Pediatrics, 47(4), pp.373~379 (2004), 대한소아과학회
  11. Kim YK, "Bloodstream infections by extended- spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome", Antimicrob Agents Chemother, 46, pp.1481~1491 (2002)
  12. Calbo E, "Risk factors for community -onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases", J Antimicrob Chemother, 57, pp.780~783 (2006)
  13. Colodner R, "Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients", Eur J Clin Microbiol Infect Dis, 23, pp.163~167 (2004)
  14. Rodrguez-Bao J, "Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients", J Clin Microbiol, 42, pp.1089~1094 (2004)
  15. Robin F, "Evaluation of the Vitek-2 extended-spectrum beta- lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases", Clin Microbiol Infect, 14, pp.148~154 (2008)
  16. Lamotte-Brasseur J, "The structures and catalytic mechanisms of active-site serine beta- lactamases", Biotechnol Genet Eng Rev, 12, pp.189~230 (1994)
  17. Paterson DL, "Extended-spectrum beta- lactamases: a clinical update", Clin Microbiol Rev, 18, pp.657~686 (2005)
  18. Cantn R, "Prevalence and spread of extended-spectrumbeta-lactamase-producing Enterobacteriaceae in Europe", Clin Microbiol Infect 14 Suppl, 1, pp.144~153 (2008)
  19. Rodrguez-Bao J, "Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge", Clin Infect Dis, 43, pp.1407~1414 (2006)
  20. Goossens H, "Prevalence and antimicrobial susceptibility data for extended-spectrum beta- lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC program in Europe and the United States (1997-2004)", Diagn Microbiol Infect Dis, 53, pp.257~264 (2005)
  21. Hirakata Y, "SENTRY Asia-Pacific Participants. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)", Diagn Microbiol Infect Dis, 52, pp.323~329 (2005)
  22. Bell JM, "Sentry APAC Study Group. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)", Diagn Microbiol Infect Dis, 42, pp.193~198 (2002)
  23. Jeong SH, "Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea", Lett Appl Microbiol, 39, pp.41~47 (2004)
  24. Jeong SH, "Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey", J Clin Microbiol, 42, pp.2902~2906 (2004)
  25. Kim J, "Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12", J Clin Microbiol, 43, pp.2452~2455 (2005)
  26. Pai H, "The characteristics of extended-spectrum beta-lactamases in Korean isolates of Enterobacteriaceae", Yonsei Med J, 39, pp.514~519 (1998)
  27. Ryoo NH, "Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea", J Antimicrob Chemother, 56, pp.698~702 (2005)
  28. Ko KS, "Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals", Diagn Microbiol Infect Dis, 61, pp.453~459 (2008)
  29. Chow JW, "In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)", Surg Infect (Larchmt), 6, pp.439~448 (2005)
  30. Valverde A, "Dramatic increase in prevalence of fecal carriage of extended-spectrum beta- lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain", J Clin Microbiol, 42, pp.4769~4775 (2004)
  31. Borer A, "Extended-spectrum beta-lactamase- producing Enterobacteriaceae strains in community- acquired bacteremia in Southern Israel", Med Sci Monit, 8, pp.CR44~CR47 (2002)
  32. Ben-Ami R, "Influx of extended-spectrum beta- lactamase-producing Enterobacteriaceae into the hospital", Clin Infect Dis, 42, pp.925~934 (2006)
  33. 김남희, "Extended-Spectrum β - Lactamase 생성 Escherichia coli에 의한 소아 요로감염의 위험인자", Korean Journal of Pediatrics, 47(2), pp.164~169 (2004), 대한소아과학회
  34. Peterson LR, "Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta- lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam", Clin Microbiol Infect 14 Suppl 1, 14, pp.181~184 (2008)
  35. Rupp ME, "Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment", Drugs, 63, pp.353~365 (2003)
  36. Sohei Harada, "Extended-spectrum β-Lactamases: Implications for the Clinical Laboratory and Therapy", The Korean Journal of Laboratory Medicine, 28(6), pp.401~412 (2008), 대한진단검사의학회
  37. Pitout JD, "Extended-spectrum beta- lactamase-producing Enterobacteriaceae: an emerging public-health concern", Lancet Infect Dis, 8, pp.159~166 (2008)
  38. Rodrguez-Bao J, "Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective", Clin Microbiol Infect 14 Suppl, 1, pp.104~110 (2008)
  39. Arslan H, "Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey", J Antimicrob Chemother, 56, pp.914~918 (2005)
  40. Warren RE, "Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK", J Antimicrob Chemother, 61, pp.504~508 (2008)

관련 논문AI추천

지역사회 획득 소아 요로검염에서 Extended-Spectrum b-Lactamase 생성 Escherichia coli의 발생과 위험인자서정완, 신지선, 이미애, 이승주, 이정원대한소아신장학회 · Childhood Kidney Diseases2004 · 제8권 제2호Extended-Spectrum β-Lactamase 생성 균주와 비생성 균주에 의한 지역사회 획득 요로 감염 비교류일, 차한, 김규원, 선용한, 안도희, 전인상, 조혜경대한소아감염학회 · Pediatric Infection and Vaccine2015 · 제22권 제1호발열성 소아 요로감염에서 Extended-Spectrum β- Lactamase 생성 Escherichia coli의 임상적 의의박철, 김미경, 김민상, 유기환, 이주원, 임형은, 홍영숙대한소아신장학회 · Childhood Kidney Diseases2012 · 제16권 제1호An Epidemiologic Study on Hosts and Pathogens of Urinary Tract Infection in Urban Children of Korea (2012–2017)배기수, 유영명, Byeong Sub Park, Hyun Joo Jung, Kyu Jung Park, Shin Young Lee대한소아신장학회 · Childhood Kidney Diseases2019 · 제23권 제1호Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae강수영, 강현미, 강희경, 양누리, 이봉진, 이환종, 정해일, 최은화, 하일수대한감염학회 · Infection and Chemotherapy2013 · 제45권 제4호Clinical Significance of Extended-spectrum β-lactamaseproducing Bacteria in First Pediatric Febrile Urinary Tract Infections and Differences between Age Groups김지홍, 박선영대한소아신장학회 · Childhood Kidney Diseases2017 · 제21권 제2호

이 간행물의 다른 논문 (10건)

쯔쯔가무시병의 임상 특징과 진단김동민pp. 315-322신증후군 출혈열김효열pp. 323-332중환자실에 입원한 세균성 폐렴환자에서 반정량적 procalcitonin 검사의 유용성김철홍, 박선욱, 김용욱, 현인규, 이승화, 우흥정, 김현수, 김지연pp. 342-348임신부의 인플루엔자 백신 접종률 및 관련요인김미정, 이병익, 정문현, 박신구, 손동욱, 이진수, 이광수, 이승연, 박지현, 김아름pp. 349-354A Case of Esophagogastroduodenoscopy Associated Actinomycosis Presenting as Ulcers of Hard Palate유종진, 이진서, 홍지연, 류성호, 엄중식, 박소연pp. 355-358
원문 보기